19 October, 2020 | ChargePoint Technology
Many pharmaceutical companies are finding that the use of split butterfly valve (SBV) technology for the transfer of material in or out of the manufacturing process increases the integrity of the containment solution. But with the increasing use of highly potent active pharmaceutical ingredients (HPAPIs), cross contamination can occur in multi-use facilities.
In an exclusive article with Outsourcing Pharma, our Head of Solutions Engineering, Mike Avraam discussed the challenges manufacturers face when dealing with HPAPIs and how single use split butterfly valves can help.
Read the article here: